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Allergic  proctocolitis  and  enterocolitis  have  been  success-
fully  treated  with  extensively  hydrolyzed  formulas  for  many
years.1 In  1997,  our  group  and  de  Boissieu  et  al.2 in  Paris
reported  independently  two  series  of  patients  with  cow  milk
protein  induced  allergy  that  failed  to  respond  to  extensively
hydrolyzed  formulas,  but  ultimately  responded  therapeu-
tically  to  an  amino  acid-based  infant  formula.3 These
patients  were  subsequently  challenged  with  an  extensively
hydrolyzed  formula  and  indeed  their  symptoms  recurred,
conﬁrming  intolerance  to  the  extensively  hydrolyzed  prod-
uct.  IgE  binding  epitopes  have  been  demonstrated  in  both
extensively  hydrolyzed  whey  and  casein  and  are  thought
to  be  responsible  for  these  reactions.4,5 An  amino  acid-
based  formula  was  successfully  utilized  to  treat  eosinophilic
esophagitis,  conﬁrming  that  this  disorder  is  in  fact  an  allergic
process  amenable  to  dietary  therapy.6
The  percentage  of  infants  with  cow  milk  protein  allergy
who  do  not  tolerate  an  extensively  hydrolyzed  formula
appears  be  low.  Traditionally,  the  percentage  is  thought
to  be  around  5%,  but  some  have  postulated  that  it  may
be  on  the  rise.7 Despite  the  low  incidence  of  intoler-
ance  to  extensively  hydrolyzed  protein,  the  use  of  amino
acid  formulas  has  vastly  exceeded  the  predicted  usage
in  many  countries,  despite  a  signiﬁcant  increase  in  the
cost  of  therapy.  Commercial  promotions  and  government
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license (https://creativecommons.org/licenses/by/4.0/).eimbursement  policies  in  some  areas  may  have  been  par-
ially  responsible  for  this  phenomenon.  It  is  also  quite  true,
owever,  that  many  clinicians  are  not  aware  of  the  literature
upporting  the  use  of  extensively  hydrolyzed  and  amino  acid
ormulas.
Amino  acid  formulas  are  sometimes  utilized  by  clinicians
ecause  they  believe  the  clinical  response  will  be  more  rapid
r  the  relapse  rate  will  be  signiﬁcantly  lower  resulting  in  a
reater  degree  of  patient  satisfaction.  This  is  especially  true
hen  cost  to  the  patient  is  not  a  signiﬁcant  deterrent.  There
ave  been  no  randomized  studies  conducted  to  determine
he  response  rate  to  an  amino  acid  formula  versus  an  exten-
ively  hydrolyzed  protein  formula  in  allergic  infants.  Severe
nterocolitis  is  often  thought  to  be  an  indication  for  initial
se  of  an  amino  acid  formula,  and  even  recommended  in
ome  guidelines  for  the  management  of  allergic  infants.8
owever,  no  studies  have  ever  demonstrated  increased  efﬁ-
acy  of  an  amino  acid-based  formula  in  this  situation.  Amino
cid-based  products  are  often  utilized  in  allergic  esophagi-
is  based  upon  the  original  report  demonstrating  efﬁcacy
n  these  patients.  One  study,  however,  using  an  extensively
ydrolyzed  product  in  adults,  demonstrated  a  positive  symp-
omatic  response  and  provided  an  economical  alternative
herapy.9 None  have  been  done  in  children.
Is  there  reason  not  to  utilize  amino  acid  formulas  in  every
llergic  baby  other  than  cost?  Recently,  data  suggest  that
ome  of  the  peptides  present  in  extensively  hydrolyzed  for-
ulas,  especially  those  based  on  casein,  may  facilitate  the
nduction  of  tolerance.10,11 Speciﬁc  peptide  fragments  have
ow  been  identiﬁed  that  may  play  a  role  in  this  process,
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nd  this  hypothesis  has  been  preliminarily  veriﬁed  in  ani-
al  studies.11 Earlier  development  of  tolerance  to  cow  milk
rotein  of  course  is  a  much  desired  outcome  in  the  treat-
ent  of  allergic  disease.  It  also  appears  that  Lactobacillus
G,  a  well-studied  probiotic  organism  (Lactobacillus  rham-
osus  ATC  51033),  may  signiﬁcantly  augment  this  process.12
t  is  possible  other  organisms  might  do  this  as  well  but  fur-
her  research  is  needed  before  such  statements  can  be  made
ith  conﬁdence.  Nonetheless,  the  induction  of  tolerance  is
 key  goal  in  allergy  management  and  whatever  can  be  done
o  facilitate  this  process  is  certainly  important.  Oral  toler-
nce  induction  may  also  be  possible  through  desensitization,
nd  preliminary  data  look  positive  here.13
Another  issue  that  should  be  addressed  is  the  utiliza-
ion  of  strategies  to  prevent  or  reduce  the  likelihood  of  the
evelopment  of  protein  allergy  in  at  risk  populations.  Exten-
ively  hydrolyzed  casein-based  formulas  also  play  a  role
ere,  and  while  not  equally  efﬁcacious,  partially  hydrolyzed
hey-based  formulas  may  also  play  a  role.  There  are
owever  conﬂicting  data  with  partial  hydrolysates.14 Inter-
stingly,  extensively  hydrolyzed  whey-based  formulas  do  not
ppear  to  be  effective.15 Finally,  breast-feeding  is  an  excel-
ent  and  cost-effective  way  to  reduce  the  risk  of  cow  milk
rotein  allergy  in  high-risk  populations,  and  should  be  the
rst  option  if  available.  The  probiotic  Lactobacillus  GG  also
ppears  to  be  helpful  in  the  situation.16 Further  studies
re  needed  to  determine  the  ideal  age  for  introduction  of
roteins  into  the  diet  to  prevent  allergy,  as  some  population-
ased  studies  have  suggested  that  early  introduction  may  be
deal.17
Food  allergies,  and  particularly  cow  milk  protein  allergy,
long  with  other  allergies  and  autoimmune  disorders,  are
ecoming  more  common  and  more  signiﬁcant  health  care
ssues.18 The  interventions  discussed  here  and  other  modal-
ties  to  effectively  treat  and  prevent  food  allergies  will
ecome  increasingly  important  as  time  progresses.
unding
his  study  did  not  receive  funding.
onﬂicts of interest
he  author  declares  no  conﬂicts  of  interest.
eferences
1. Vandenplas Y, Deneyer M, Sacre L, Loeb H. Preliminary data on
a ﬁeld study with a new hypo-allergic formula. Eur J Pediatr.
1988;148:274--7.2. de Boissieu D, Matarazzo P, Dupont C. Allergy to exten-
sively hydrolyzed cow milk proteins in infants: identiﬁcation
and treatment with an amino acid-based formula. J Pediatr.
1997;131:744--7.
1Vanderhoof  JA
3. Vanderhoof JA, Murray ND, Kaufman SS, Mack DR, Antonson DL,
Corkins MR, et al. Intolerance to protein hydrolysate infant for-
mulas: an underrecognized cause of gastrointestinal symptoms
in infants. J Pediatr. 1997;131:741--4.
4. Hoffman KM, Sampson HA. Serum speciﬁc-IgE antibodies to pep-
tides detected in a casein hydrolysate formula. Pediatr Allergy
Immunol. 1997;8:185--9.
5. Klemola T, Vanto T, Juntunen-Backman K, Kalimo K, Korpela R,
Varjonen E. Allergy to soy formula and to extensively hydrolyzed
whey formula in infants with cow’s milk allergy: a prospective,
randomized study with a follow-up to the age of 2 years. J
Pediatr. 2002;140:219--24.
6. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Samp-
son HA. Eosinophilic esophagitis attributed to gastroesophageal
reﬂux: improvement with an amino acid-based formula. Gas-
troenterology. 1995;109:1503--12.
7. Sicherer SH, Sampson HA. Food allergy: epidemiology, patho-
genesis, diagnosis, and treatment. J Allergy Clin Immunol.
2014;133:291--307.
8. Caffarelli C, Baldi F, Bendandi B, Calzone L, Marani M,
Pasquinelli P. Cow’s milk protein allergy in children: a practical
guide. Ital J Pediatr. 2010;36:5.
9. Lucendo AJ, Arias A, Gonzalez-Cervera J, Mota-Huertas T,
Yague-Compadre JL. Tolerance of a cow’s milk-based hydrolyzed
formula in patients with eosinophilic esophagitis triggered by
milk. Allergy. 2013;68:1065--72.
0. Heine RG. Preventing atopy and allergic disease. Nestle Nutr
Inst Workshop Ser. 2014;78:141--53.
1. Visser JT, Bos NA, Harthoorn LF, Stellaard F, Beijer-Liefers S,
Rozing J, et al. Potential mechanisms explaining why hydrolyzed
casein-based diets outclass single amino acid-based diets in the
prevention of autoimmune diabetes in diabetes-prone BB rats.
Diabetes Metab Res Rev. 2012;28:505--13.
2. Berni CR, Di CM, Pezzella V, Cosenza L, Granata V, Terrin
G, et al. The potential therapeutic efﬁcacy of Lactobacillus
GG in children with food allergies. Pharmaceuticals (Basel).
2012;5:655--64.
3. Luyt D, Bravin K, Luyt J. Implementing speciﬁc oral tolerance
induction to milk into routine clinical practice: experience from
ﬁrst 50 patients. J Asthma Allergy. 2014:1--9.
4. Silva D, Geromi M, Halken S, Host A, Panesar SS, Muraro A,
et al. Primary prevention of food allergy in children and adults:
systematic review. Allergy. 2014;6:581--9.
5. von BA, Filipiak-Pittroff B, Kramer U, Hoffmann B, Link E,
Beckmann C, et al. Allergies in high-risk schoolchildren after
early intervention with cow’s milk protein hydrolysates: 10-year
results from the German Infant Nutritional Intervention (GINI)
study. J Allergy Clin Immunol. 2013;131:1565--73.
6. Cosenza L, Nocerino R, di Scala C, di Constanzo M, Amoroso A,
Leone L, et al. Bugs for atopy: the Lactobacillus rhamnosus GG
strategy for food allergy prevention and treatment in children.
Benef Microbes. 2015;6:225--32.
7. Paparo L, di Constanzo M, di Scala C, Cosenza L, Leone L,
Nocerino R, et al. The inﬂuence of early life nutrition on epige-
netic regulatory mechanisms of the immune system. Nutrients.
2014;6:4706--19.8. Katz Y, Goldberg MR, Rajuan N, Cohen A, Leshno M. The preva-
lence and natural course of food protein-induced enterocolitis
syndrome to cow’s milk: a large-scale, prospective population-
based study. J Allergy Clin Immunol. 2011;127:647--53.
